This review emphasizes the role of angiogenesis in tissue engineering, introduces various angiogenic growth factors, and highlights current status of delivery systems for angiogenic growth factors using natural and synthetic biomaterials. A short overview of angiogenic growth factors is presented, followed by the introduction of emerging strategies for designing smart delivery carriers.
Fukuda, S. and Maulik, N. (2004). Angiogenic Strategy for Human Ischemic Heart Disease , Mol. Cell Biochem., 264(1-2): 143-149 .
2.
Tarzami, S. T. and Singh, J. P. (2004). Pharmacological Revascularisation in Coronary and Peripheral Vascular Disease , Expert Opin. Investig. Drugs, 13(10): 1319-1326 .
3.
Syed, I. S. and Rosengart, T. K. (2004), Therapeutic Angiogenesis , Cardiology, 101(1-3): 131-143 .
4.
Mooney, D. J. and Mikos, A. G. (1999). Growing New Organs , Sci. Am., 280: 60-65 .
5.
Bottaro, D. P. , Liemann-Vinson, A. and Heidaran, H. A. (2002). Molecular Signaling in Bioengineered Tissue Microenvironments , Ann. NY Acad. Sci., 961: 143-153 .
6.
Hariawala, M. D. and Esakof, D. (1996). VEGF Improves Myocardial Blood Flow but Produces EDRF-mediated Hypotension in Porcine Hearts , J. Surg. Res., 63: 77-82 .
7.
Lazarous, D. F. and Uger, E. F. (1997). Pharmacodynamics of Basic Fibroblast Growth Factor , Cardiovasc. Res., 36: 78-85 .
8.
Wong, C. and Helgerson, S. (2003). Fibrin-based Biomaterials to Deliver Human Growth Factors , Thromb. Haemost., 89: 573-582 .
9.
L’Heureux, N. and Auger, F. A. (1993). In Vitro Construction of a Human Blood Vessel from Cultured Vascular Cells , J. Vasc. Surg., 17: 499-509 .
10.
Draget, K. I. and Smidsrod, O. (1997). Alginate Based New Materials , Int. J. Biol. Macromol., 21: 47-55 .
11.
Lee, H. and Vacanti, J. P. (2002). Local Delivery of Basic Fibroblast Growth Factor Increases both Angiogenesis and Engraftment of Hepatocytes in Tissue Engineered Polymer Devices , Transplantation, 73: 1589-1589 .
12.
Hubbell, J. A. (1999). Bioactive Biomaterials , Curr. Opin. Biotechnol., 10: 123-129 .
13.
Sakiyama, S. E. and Hubbell, J. A. (2000). Development of Fibrin Derivatives for Controlled Release of Heparin-binding Growth Factors , J. Control. Rel., 65: 389-402 .
14.
Richardson, T. P. and Mooney, D. J. (2001). Polymeric System for Dual Growth Factor Delivery , Nat. Biotechnol., 19: 1029-1034 .
15.
Seliktar, D. and Hubbell, J. A. (2004). MMP-2 Sensitive, VEGF-bearing Bioactive Hydrogels for Promotion of Vascular Healing , J. Biomed. Mater. Res., 68A(4): 704-716 .
16.
West, J. L. and Hubbell, H. A. (1999). Polymeric Biomaterials with Degradation Sites for Proteases Involved in Cell Migration , Macromolecules, 32: 241-244 .
17.
Mann, B. K. and West, J. L. (2001). Smooth Muscle Cell Growth in Photopolymerized Hydrogels with Cell Adhesive and Proteolytically Degradable Domains: Synthetic ECM Analogs for Tissue Engineering , Biomaterials, 22: 3045-3051 .
18.
Kawasuji, M. (2002). Therapeutic Angiogenesis for Ischemic Heart Disease , Ann. Thorac. Cardiovasc. Surg., 8(2): 59-61 .
19.
Hirschi, K. K. and Little, C. D. (2002). Vascular Assembly in Natural and Engineered Tissues , Ann. NY Acad. Sci., 961: 223-242 .
20.
Carmeliet, P. (2000). Mechanisms of Angiogenesis and Arteriogenesis , Nat. Med., 6: 389-395 .
21.
Rafii, S. and Lyden, D. (2003). Therapeutic Stem Cell Progenitor Cell Transplantation for Organ Vascularization and Regeneration , Nat. Med., 9: 702-712 .
22.
Liekens, S. and Neyts, J. (2001). Angiogenesis: Regulators and Clinical Applications , Biochem. Pharmacol., 61: 253-270 .
23.
Ferrara, N. and LeCouter, J. (2003). The Biology of VEGF and its Receptors , Nat. Med., 9: 669-676 .
24.
Ferrara, N. (2001). Role of Vascular Endothelial Growth Factor in Regulation of Physiological Angiogenesis , Am. J. Physiol. Cell Physiol., 280: c1358-c1366 .
25.
Davies, J. E. (ed.) (2000). Bone Engineering, 137-147, Em Squared, Toronto .
26.
Luttun, A. and Carmeliet, P. (2002). Placental Growth Factor (PlGF) and its Receptor Flt-1 (VEGFR-1): Novel Therapeutic Targets for Angiogenic Disorders , Ann. NY Acad. Sc., 979: 80-93 .
27.
Gerwins, P. and Claesson-Welsh, L. (2000). Function of Fibroblast Growth Factors and Vascular Endothelial Growth Factors and their Receptors in Angiogenesis , Crit. Rev. Oncol. Hematol., 34: 185-185 .
28.
Li, J. and Kirsner, R. S. (2003). Angiogenesis in Wound Repair: Angiogenic Growth Factors and the Extracellular Matrix , Microsc. Res. Tech., 60: 107-107 .
29.
Nugent, M. A. and Iozzo, R. V. (2000). Fibroblast Growth Factor-2 , Int. J. Biochem. Cell Biol., 32: 115-115 .
30.
Delli Castelli, M. and Leslie, R. D. (2003). Diabetic Retinopathy: Medical Management and Assessment , Hosp. Med., 64: 400-400 .
31.
Soker, S. and Atala, A. (2000). Systems for Therapeutic Angiogenesis in Tissue Engineering , World J. Urol., 18: 10-10 .
32.
Isner, J. M. and Assahara, T. (1999). Therapeutic Angiogenesis , Front. Biosci., 3: e49-e69 .
33.
Darland, D. C. and D’Amore, P. A. (2001). TGF is Required for the Formation of Capillary-like Structures in Three-dimensional Cocultures of 10T1/2 and Endothelial Cells , Angiogenesis, 4: 11-11 .
34.
Dvorak, H. F. and Carvalho, A. C. (1979). Induction of a Fibrin-gel Investment: An Early Event in 10 Hepatocarcinoma Growth Mediated by Tumor-secreted Products , J. Immunol., 122: 166-174 .
35.
Baird, A. and Bohlen, P. (1992). Isolation and Partial Characterization of an Endothelial Cell Growth Factor from the Bovine Kidney: Homology with Basic Fibroblast Growth Factor , Regul. Pept., 12: 201-213 .
36.
Esch, F. and Ling, N. (1985). Primary Structure of Bovine Pituitary Basic Fibroblast Growth Factor (FGF) and Comparison with the Amino-Terminal Sequence of Bovine Brain Acidic FGF , Proc. Natl. Acad. Sc., 82: 6501-6511 .
37.
Connolly, D. T. and Heuvelman, D. (1989). Human Vascular Permeability Factor. Isolation from U937 Cells , J. Biol. Chem., 264: 20017-20024 .
38.
Unger, E. F. and Shou, M. (1991). Heparin Promotes the Formation of Extracardiac to Coronary Anastomoses in a Canine Model , Am. J. Physiol. Heart Circ. Physiol., 260: h1625-h1634 .
39.
Quyyumi, A. A. and Lakatos, E. (1993). Angiogenic Effects of Low Molecular Weight Heparin in Patients with Stable Coronary Artery Disease: A Pilot Study , J. Am. Coll. Cardiol., 22: 635-641 .
40.
Beck, C. S. (1935). The Development of a New Blood Supply to the Heart by Operation , Ann. Surg., 102: 801-806 .
41.
Vineberg, A. M. and Pirozynski, W. J. (1966). Experimental Revascularization of the Entire Heart: Evaluation of Epicardiectomy, Omental Graft, and/or Implantation of the Internal Mammary Artery in Preventing Myocardial Necrosis and Death of the Animal , Am. Heart J., 72: 79-93 .
42.
Connolly, D. T. and Nelson, R. (1989). Tumor Vascular Permeability Factor Stimulates Endothelial Cell Growth and Angiogenesis , J. Clin. Invest., 84: 1470-1478 .
43.
Pepper, M. S. and Orci, L. (1991). Vascular Endothelial Growth Factor Induces Plasminogen Activators and Plasminogen Activator Inhibitor-1 in Microvascular Endothelial Cells , Biochem. Biophys. Res. Commun., 181: 902-906 .
44.
Leung, D. W. and Kuang, W. J. (1989). Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen , Science, 246: 1306-1309 .
45.
Wilting, J. and Weich, H. A. (1992). The Effects of Growth Factors on the Day 13 Chorioallantoic Membrane (CAM): A Study of VEGF165 and PDGF-BB , Anat. Embryol., 186: 251-257 .
46.
Vajanto, I. and Yla-herttuala, S. (2002). Evaluation of Angiogenesis and Side Effects in Ischemic Rabbit Hindlimbs after Intramuscular Injection of Adenoviral Vectors Encoding VEGF and LacZ , J. Gene Med., 4(4): 371-380 .
47.
Epstein, S. E. and Kornowski, R. (2001). Therapeutic Interventions for Enhancing Collateral Development by Administration of Growth Factors , Cardiovasc. Res., 49: 532-542 .
48.
Lazarous, D. F. and Scheinowitz, M. (1996). Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury , Circulation, 94: 1074-1082 .
49.
Lee, K. Y. and Mooney, D. J. (2003). Comparison of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis in SCID Mice , J. Control. Rel., 87: 49-56 .
50.
Albini, A. and Noonan, D. M. (2000). Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-producing Cells , Am. J. Pathol., 156: 1381-1381 .
51.
Isner, J. M. (2002). Myocardial Gene Therapy , Nature, 415: 234-239 .
52.
Whitelock, J. M. and Underwood, P. A. (1996). The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelyson, Collagenase, Plasmin, and Heparanases , J. Biol. Chem., 271: 10079-11086 .
53.
Hung, W. S. and Tsai, Y. H. (2001). Effect of SACCHACHITIN on Keratinocyte Proliferation and the Expression of Type I Collagen and Tissue Transglutaminase During Skin Wound Healing , J. Biomed. Mater. Res., 56: 93-93 .
54.
Ramirez, F. and Rifkin, D. B. (2003). Cell Signaling Events: A View from the Matrix . Matrix Biol., 22: 101-107 .
55.
Whitelock, J. M. and Underwood, P. A. (1996). The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases , J. Biol. Chem., 271: 10079-11086 .
56.
Shelly, E. and Hubbell, J. A. (2000). Development of Fibrin Derivatives for Controlled Release of Heparin-binding Growth Factors , J. Control. Rel., 65: 389-402 .
57.
Sahni, A. and Francis, C. W. (1999). Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2 , J. Biol. Chem., 274: 14936-14941 .
58.
Sahni, A. and Francis, C. W. (2000). Fibrinogen and Fibrin Protect Fibroblast Growth Factor-2 from Proteolytic Degradation , Thromb. Haemost., 83: 736-741 .
59.
L’Heureux, N. and Auger, F. A. (1993). In Vitro Construction of a Human Blood Vessel from Cultured Vascular Cells: a Morphologic Study , J. Vasc. Surg., 17: 499-509 .
60.
Auger, F. A. and Germain, L. (1995). Skin Equivalent Produced with Human Collagens , In Vitro Cell Dev. Biol. Anim., 31: 432-429 .
61.
Tabata, Y. and Ikada, T. (2000). Controlled Release of Vascular Endothelial Growth by Use of Collagen Hydrogels , J. Biomater. Sci. Polymer Edn., 11: 915-915 .
62.
Pieper, J. S. and Kuppevelt, T. H. (2002). Loading of Collagen-heparan Sulfate Matrices with bFGF Promotes Angiogenesis and Tissue Generation in Rats , J. Biomed. Mater. Res., 62: 185-194 .
63.
Yamanoto, M. and Tabata, T. (2001). Controlled Release of Growth Factors Based on Biodegradation of Gelatin Hydrogel , J. Biomater. Sci. Polymer Edn., 12: 77-77 .
64.
Smidsrod, O. and Skjak-Braek, G. (1990). Alginate as Immobilization Matrix for Cells , Trends Biotechol., 8: 71-78 .
65.
Ostterlei, M. and Espevik, V. (1991). Induction of Cytokine Production from Human Monocytes Stimulated with Alginate , J. Immunother., 10: 286-291 .
66.
Schuch, G. and Soker, S. (2002). In Vivo Administration of Vascular Endothelial Growth Factor (VEGF) and its Antagonist, Soluble Neuropilin-1, Predicts a Role of VEGF in the Progression of Acute Myeloid Leukemia In Vivo , Blood, 100: 4622-4628 .
67.
Dons, E. C. and Plunkett, M. L. (1992). Calcium Alginate Beads as a Slow-release System for Delivering Angiogenic Molecules In Vivo and In Vitro , J. Cell Physiol., 152: 422-429 .
68.
Tanihara, M. and Mizushima, Y. (2001). Sustained Release of Basic Fibroblast Growth Factor and Angiogenesis in a Novel Covalently Crosslinked Gel of Heparin and Alginate , J. Biomed. Mater. Res., 56: 216-216 .
69.
Forrester, J. V. and Balasz, E. A. (1980). Inhibition of Phagocytosis by High Molecular Weight Hyaluronate , Immunology, 40: 435-446 .
70.
Kujawa, M. J. and Caplan, A. I. (1986). Substrate-bonded Hyaluronic Acid Exhibits a Size-dependent Stimulation of Chondrogenic Differentiation , Dev. Biol., 144: 519-528 .
71.
Goldberg, R. L. and Toole, B. P. (1987). Hyaluronate Inhibition of Cell Proliferation , Arthritis Rheum., 30: 769-778 .
72.
Forrester, J. V. and Balasz, E. A. (1980). Inhibition of Phagocytosis by High Molecular Weight Hyaluronate , Immunology, 40: 435-446 .
73.
Kujawa, M. J. and Caplan, A. O. (1986). Substrate-bounded Hyaluronic Acid Exhibits a Size-dependent Stimulation of Chondrogenic Differentiation of Stage 24 Limb Mesenchymal Cells in Culture , Dev. Biol., 144: 519-528 .
74.
Montesano, R. and Pepper, M. S. (1996). Synergistic Effect of Hyaluronan Oligosaccharides and Vascular Endothelial Growth Factor on Angiogenesis In Vitro , Lab. Invest., 75: 259-266 .
75.
Peattie, R. A. and Prestwich, G. D. (2004). Stimulation of In Vivo Angiogenesis by Cytokine Loaded Hyaluronic Acid Hydrogel Implants , Biomaterials, 25: 2789-2798 .
76.
Bulpitt, P. and Aeschlimann, D. (1999). New Strategy for Chemical Modification of Hyaluronic Acid , J. Biomed. Mater. Res., 47(2): 152-169 .
77.
Levenberg, S. and Langer, R. (2004). Advance in Tissue Engineering , Curr. Top. Dev. Biol., 61: 113-134 .
78.
Ratner, B. D. and Bryant, S. J. (2004). Biomaterials: Where We Have Been Where We Are Going , Annu. Rev. Biomed. Eng., 6: 41-75 .
79.
Nam, Y. S. and Park, T. G. (1999). Porous Biodegradable Polymeric Scaffolds Prepared by Thermally Induced Phase Separation , J. Biomed. Mater. Res., 47: 8-17 .
80.
King, T. W. and Patrick, C. W. (2000). Development and In Vitro Characterization of Vascular Endothelial Growth Factor (VEGF)-loaded Poly(DL-lactic-co-glycolic acid)/Poly(ethylene glycol) Microspheres Using a Solid Encapsulation/Single Emulsion/Solvent Extraction Technique , J. Biomed. Mater. Res., 51: 383-383 .
81.
Park, T. G. (1995). Degradation of Poly(lactic-co-glycolic acid) Microspheres: Effect of Copolymer Composition , Biomaterials, 16: 1123-1130 .
82.
Kim, H. K. and Park, T. G. (2004). Comparative Study on Sustained Release of Human Growth Hormone from Semi-crystalline Poly(L-lactic acid) and Amorphous Poly(D, L-lactic-co-glycolic acid) Microspheres: Morphological Effect on Protein Release , J. Control. Rel., 98: 115-125 .
83.
Park, T. G. (1994). Degradation of Poly(D, L-lactic acid) Microspheres: Effect of Molecular Weight , J. Control. Rel., 30: 161-173 .
84.
Bouhadir, K. H. and Mooney, D. J. (2001). Promoting Angiogenesis in Engineered Tissues , J. Drug Target., 9: 397-397 .
85.
Nam, Y. S. , Yoon, J. J. and Park, T. G. (2000). A Novel Fabrication Method for Macroporous Scaffolds Using Gas Foaming Salt as Porogen Additive , J. Biomed. Mater. Res. (Appl. Biomat.), 53: 1-7 .
86.
Sheridan, M. and Mooney, D. J. (2000). Bioabsorbable Polymer Scaffolds for Tissue Engineering Capable of Sustained Growth Factor Delivery , J. Control. Rel., 64: 91-91 .
87.
Kim, H. K. and Park, T. G. (1999). Microencapsulation of Human Growth Hormone within Biodegradable Polyester Microspheres: Protein Aggregation Stability and Incomplete Release Mechanism , Biotech. Bioeng., 65: 659-667 .
88.
Sakakibara, Y. and Tabata, T. (2003). Toward Surgical Angiogenesis Using Slow-released Basic Fibroblast Growth Factor , Eur. J. Cardiothorac. Surg., 24: 105-105 .
89.
Cleland, J. L. and Cuthbertson, A. (2001). Development of Poly-(D, L-lactide-co-glycolide) Microsphere Formulations Containing Recombinant Human Microspheres Using a Rat Model , J. Control. Rel., 72: 13-24 .
90.
Kim, T. K. and Burgess, D. J. (2002). Pharmacokinetic Characterization of 14C-vascular Endothelial Growth Factor Controlled Release Microspheres Using a Rat Model , J. Pharm. Pharmacol., 54: 897-905 .
91.
Crotts, G. and Park, T. G. (1998). Protein Delivery from Poly(lactic-co-gly-colic acid) Biodegradable Microspheres: Release Kinetics and Stability Issues , J. Microencapsulation, 15: 699-713 .
92.
Lee, H. and Park, T. G. (2002). Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of In Vitro Biological Activity , Pharmaceut. Res., 19: 845-851 .
93.
Kim, T. H. , Lee, H. and Park, T. G. (2002). Pegylated Recombinant Human Epidermal Growth Factor (rhEGF) for Sustained Release from Biodegradable PLGA Microspheres , Biomaterials, 23: 2311-2317 .
94.
Cruise, G. M. and Hubbell, J. A. (1998). Characterization of Permeability and Network Structure of Interfacially Photopolymerized Poly(ethylene glycol) Diacrylate Hydrogels , Biomaterials, 19: 1287-1294 .
95.
Bryant, S. J. and Anseth, K. S. (2001). The Effects of Scaffold Thickness on Tissue Engineered Cartilage in Photocrosslinked Poly(ethylene oxide) Hydrogels , Biomaterials, 22: 619-626 .
96.
Huh, K. M. and Bae, T. G. (1999). Synthesis and Characterization of Poly(ethylene glycol)/Poly(L-lactic acid) Alternating Multiblock Copolymers , Polymer, 40: 6147-6155 .
97.
Metters, A. T. and Anseth, K. S. (2000). Fundamental Studies of a Novel, Biodegradable PEG-b-PLA Hydrogel , Polymer, 41: 3993-4004 .
98.
Richardson, T. P. and Mooney, D. J. (2001). Polymeric Systems for Dual Growth Factor Delivery , Nat. Biotechnol., 19: 1029-1034 .
99.
Holland, T. A. and Mikos, A. G. (2005). Dual Growth Factor Delivery from Degradable Oligo(poly(ethylene glycol) fumarate) Hydrogel Scaffolds for Cartilage Tissue Engineering , J. Control. Release, 3: 101(1-3): 111-125 .
100.
Cao, R. and Cao, Y. (2003). Angiogenic Synergism, Vascular Stability and Improvement of Hind-limb Ischemia by a Combination of PDGF-BB and FGF-2 , Nat. Med., 9: 604-613 .
101.
Calza, L. and Levi-Montalcini, R. (2001): Nerve Growth Factor Control of Neuronal Expression of Angiogenic and Vasoactive Factors , Proc. Natl. Acad. Sci., 98: 4160-4165 .
102.
Kim, M. R. and Park, T. G. (2002). Temperature-responsive and Degradable Hyaluronic Acid/Pluronic Composite Hydrogels for Controlled Release of Human Growth Hormone , J. Control. Rel., 80(1-3): 69-77 .
